Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Ribavirin for RSV in BMT Recipients
NCT00031473Phase 3Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 1997
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of ribavirin in respiratory syncytial virus infection (RSV), sponsored by National Institute of Allergy and Infectious Diseases. Started Nov 1997; status: terminated.
02
Drugs
ribavirin
03
Conditions
respiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT00031473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00031473.